N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine
C23H25N5O — CID 156844615
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine
N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine (PubChem CID 156844615) has the molecular formula C23H25N5O and a molecular weight of 387.49 g/mol. Its IUPAC name is N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine.
Molecular Properties
| Compound Name | N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine |
|---|---|
| PubChem CID | 156844615 |
| Molecular Formula | C23H25N5O |
| Molecular Weight | 387.49 g/mol |
| Exact Mass | 387.21 |
| IUPAC Name | N-[(1S,5R)-9-azabicyclo[3.3.1]nonan-3-yl]-8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-amine |
| SMILES | c1cnn(-c2ccc3c(c2)COc2nc(NC4C[C@H]5CCC[C@@H](C4)N5)ccc2-3)c1 |
| InChI | InChI=1S/C23H25N5O/c1-3-16-12-18(13-17(4-1)25-16)26-22-8-7-21-20-6-5-19(28-10-2-9-24-28)11-15(20)14-29-23(21)27-22/h2,5-11,16-18,25H,1,3-4,12-14H2,(H,26,27)/t16-,17+,18? |
| InChIKey | HJUWHYPUQXDPJW-JWTNVVGKSA-N |
| XLogP | 3.91 |
| TPSA | 64.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.49 |
| LogP ≤ 5 | 3.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156844615 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.